The association of serum markers of fibrosis and development of liver cirrhosis in chronic hepatitis B patients: A systematic review and meta-analysis

References

• Cai, G. F., Wang, Z. T., Yao, J., Liu, K., Wang, Z. F., Chen, Y. D., Lv, H. K., Zhou, B., Hu, C. G. (2018). The correlation between serum cytokine levels and liver cirrhosis in chronic hepatitis B patients: A meta-analysis. Archives of Hepatitis Research. The correlation between serum cytokine levels and liver cirrhosis in chronic hepatitis B patients: A meta-analysis. Archives of Hepatitis Research, 4(1), 6–12. doi:10.17352/ahr.000019.
   Google Scholar
• Cao, B. H., Wen, F. Y., & Ye, C. L. (2008). Relationship between serum HBV DNA levels and hepatic fibrosis markers in chronic hepatitis B. Laboratory Medicine and Clinic, 5(7), 398–399.
   Google Scholar
• Chen, F., Xiao, Y. Q., Chen, C. Y., & Tu, X. L. (2009). Study on Relationship between Liver Pathological and Clinic Characteristics in Patients with Chronic Hepatitis BPractical. Clinical Medicine, 10(4), 20–22.
   Google Scholar
• Chen, Z. W., Ye, X. G., Yu, X., Huang, Y. M., & Zuo, S. H. (2007). Study on the level of insulin - like growth factor - 1 and its relationship with serum markers of hepatic fibrosis in chronic hepatitis B. Chinese Journal of Clinical Hepatology, 23(1), 15–16.
   Google Scholar
• Chu, C. M., & Liaw, Y. F. (2006, May). Hepatitis B virus-related cirrhosis: Natural history and treatment. Seminars in Liver Disease, 26(2), 142–152. doi:10.1055/s-2006-939752
   PubMed Web of Science ®Google Scholar
• de Jongh, F. E., Janssen, H. L., de Man, R. A., Hop, W. C., Schalm, S. W., & van Blankenstein, M. (1992). Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver. Gastroenterology, 103(5), 1630–1635.
   PubMed Web of Science ®Google Scholar
• Dong, Z., Shen, H., & Zhang, F. K. (2007). Relationship between serum HBV DNA levels and hepatic fibrosis markers in chronic hepatitis B. Chinese Journal of Experimental and Clinical Virology, 21(2), 129–131.
   PubMedGoogle Scholar
• Du, W. J., Han, S. L., Xu, Y., Qin, L. Y., & Chen, S. J. (2010). Relationship between intrahepatic interleukin-17 expression and hepatic fibrosis in chronic hepatitis B virus infection. Chinese Journal of Infectious Diseases, 28(6), 359–363.
   Google Scholar
• Fattovich, G., Pantalena, M., Zagni, I., Realdi, G., Schalm, S. W., Christensen, E. (2002, November). Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: A cohort study of 297 patients. The American Journal of Gastroenterology, 97(11), 2886–2895. doi:10.1111/j.1572-0241.2002.07057.x
   PubMed Web of Science ®Google Scholar
• Friedman, S. L., & Bansal, M. B. (2006). Reversal of hepatic fibrosis-fact or fantasy. Hepatology, 42(2 Suppl 1), 882–888.
   Google Scholar
• He, Z. B., Zhu, J. S., Zeng, W. X., Chen, H. Z., Wang, G. G., Fang, H. (2007). Significance of the serum level of transforming growth factor β1 and its difference in patients with chronic hepatitis B and HBV-induced hepatic cirrhosis. World Chinese Journal of Digestology, 15(29), 3104–3106.
   Google Scholar
• Hong, Y. M., Huang, S. Y., & Ruan, Y. H. (2010). Analysis of atypical hepatitis B cirrhosis. Journal of Chinese Physician, (suppl 2), 123–125.
   Google Scholar
• Huang, G. D., Xie, Y. Q., Yang, B. X., & Huang, F. (2015). Study of serum TGF-β1 levels in patients with chronic hepatitis B virus infection and its correlation with hepatic fibrosis. Hainan Medical Journal, 26(13), 1890–1891.
   Google Scholar
• Jiang, M. Y., Zhang, Z. Y., Hu, W. P., & Wu, Q. B. (2010). Comparison of several biochemical and immunological indexes in patients with liver. China’s Traditional Chinese Medicine Information, 28, 220–221.
   Google Scholar
• Jury, E. (2003, April). International Consensus Conference on Hepatitis B 13-14 September 2002: Geneva Switzerland Consensus statement (short version). Journal of Hepatology, 38(4), 533–540.
   PubMedGoogle Scholar
• Kang, Y., Shang, J., Li, X. L., & Yang, Y. X. (2006). Detection of Serum Transforming Growth Factor β-1 and Leptin in Chronic Hepatitis B and Hepatitis Cirrhosis of Liver Patients. Chinese Journal of Clinical Gastroenterology, 18(5), 270–274.
   Google Scholar
• Key documents. (2017, January 11) Retrieved from http://wwwprisma-statementorg/
   Google Scholar
• Li, J. H., He, X. F., & Li, X. C. (2007). Detection of Serum Activin A in Patients with Hepatitis B and Its Clinical Significance. Clinical Focus, 22(16), 1172–1173.
   Google Scholar
• Liang, D. Y., Lou, X. L., & Hou, Y. Q. (2013). Application value of serum UⅡin chronic hepatitis B liver fibrosis and liver cirrhosis. Laboratory Medicine and Clinic, 10(18), 2359–2362.
   Google Scholar
• Liang, X. F., Chen, Y. S., Wang, X. J., He, X., Chen, L. J., Wang, J., Lin, C. Y., Bai, H. Q., Yan, J., Cui, G., Yu, J. J. (2005). Study on the sero-epidemiology of hepatitis B in Chinese population aged over 3-years old. Chinese Journal of Epidemiology, 26, 4–8.
   Google Scholar
• Lin, D. X., Gao, Y. L., Huang, W. M., & Zhang, P. (2006). Stepwise Discriminate Analysis of Serological Detection of the Viral Hepatitis B. Journal of Fujian Medical University, 40(1), 44–47.
   Google Scholar
• Liu, T., Li, Q., & Xie, R. Z. (2014). Study on the Correlation between the Serum Cholinesterase of Patients with Chronic Hepatitis B Liver Cirrhosis and Hepatic Fibrosis Serum Markers. Journal of Weifang Medical College, 1, 39–41.
   Google Scholar
• Liu, W. Y. Relationship between RAS changes and hepatic fibrosis indicators with hepatic B and hepatic cirrhosis. Xinjiang medical university. 2015; 8. doi:10.1094/PDIS-09-14-0954-PDN
   Google Scholar
• Lu, M. H., Zhang, J. Y., & Yang, H. W. (2015). Research on the Relationship between Serum Fibrosis Indexes and Liver Function in Patients with Cirrhosis Hepatitis B. Medical Recapitulate, 21(24), 4544–4546.
   Google Scholar
• Orsatti, G., Hytiroglou, P., Thung, S. N., Ishak, K. G., & Paronetto, F. (1997). Lamellar fibrosis in the fibrolamellar variant of hepatocellular carcinoma: A role for transforming growth factor beta. Liver, 17, 152–159.
   PubMedGoogle Scholar
• Schuppan, D., & Afdhal, N. H. (2008, March). Liver cirrhosis. Lancet (London England), 371(9615), 838–851. doi:10.1016/S0140-6736(08)60383-9
   PubMed Web of Science ®Google Scholar
• Wang, P., & Chang, P. (2011). The clinical study of T cell subgroup, tumor necrosis factor - alpha, interleukin-6 and interleukin-8 in hepatitis B after hepatitis B. Chinese Journal of Postgraduate Medicine, 34, 70–72.
   Google Scholar
• Wei, L. Correlation between Toll-like receptor 4 on peripheral blood mononuclear cells (PBMC) and serum TGF-βin patients with chronic hepatitis B Virus infection. Lanzhou University. 2009; 11
   Google Scholar
• Yang, Q., Hai, S. H., Zhang, X. N., & Wang, S. (2010). Serum levels and clinical evaluation of activin A in patients with chronic hepatitis B and its clinical evaluation. Laboratory Medicine and Clinic, 7(21), 2356–2357.
   Google Scholar
• Zhang, J. J., Wu, L. P., Du, R. Q., Wang, J. B., Yao, Z. C., Yu, G. Q. (2013). Study on the correlation between liver histopathological changes and platelet counts and serum hepatic fibrosis indicators in patients with chronic hepatitis B. Practical Hepatology, 15(3), 226–228.
   Google Scholar
• Zhang, L. J. (2013). Clinical examination of hematological indexes in patients with liver cirrhosis. Chinese Medical Statistics, 20(2), 97–99.
   Google Scholar
• Zhang, X. Y., Yang, Y., Sheng, H. P., & Lai, Y. F. (2010). Relationship between serum levels of transforming growth factor β1 and hepatic fibrosis in chronic hepatitis B patients. Shandong Medical Journal, 50(45), 4–6.
   Google Scholar
• Zhou, J. F., He, J. F., Dai, L. C., Liu, J., Wang, W. H., & Qian, F. C. (2006). The change and significance of serum TIMP −1 and TIMP −2 levels in patients with chronic hepatitis B and liver cirrhosis. Laboratory Medicine, 21(3), 248–250.
   Google Scholar
• Zhou, Q., Huang, Q. Q., & Huang, L. Q. (2013). The correlation between hepatic fibrosis and hepatic puncture was analyzed in 74 patients with chronic hepatitis. Medical Test, 20(1), 97–98.
   Google Scholar
• Zhu, Y. J. Combined serum fibrosis markers and portal perfusion index to evaluate chronic hepatitis B and cirrhosis. Zhejiang University. 2011; 10
   Google Scholar